ATWCX
Price
$25.31
Change
-$0.70 (-2.69%)
Updated
Oct 10 closing price
Net Assets
970.38M
RWICX
Price
$73.48
Change
-$1.91 (-2.53%)
Updated
Oct 10 closing price
Net Assets
142.2B
Interact to see
Advertisement

ATWCX vs RWICX

Header iconATWCX vs RWICX Comparison
Open Charts ATWCX vs RWICXBanner chart's image
AB Tax-Managed Wealth Apprec Strat C
Price$25.31
Change-$0.70 (-2.69%)
VolumeN/A
Net Assets970.38M
American Funds Capital World Gr&Inc R3
Price$73.48
Change-$1.91 (-2.53%)
VolumeN/A
Net Assets142.2B
ATWCX vs RWICX Comparison Chart in %
View a ticker or compare two or three
VS
ATWCX vs. RWICX commentary
Oct 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATWCX is a Buy and RWICX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWICX has more cash in the bank: 142B vs. ATWCX (970M). RWICX pays higher dividends than ATWCX: RWICX (1.14) vs ATWCX (0.00). ATWCX was incepted earlier than RWICX: ATWCX (22 years) vs RWICX (23 years). ATWCX (2.06) is less costly to investors than RWICX (1.06). RWICX is a more actively managed with annual turnover of: 27.00 vs. ATWCX (10.00). RWICX has a lower initial minimum investment than ATWCX: RWICX (250) vs ATWCX (2500). ATWCX annual gain was more profitable for investors over the last year : 15.50 vs. RWICX (8.89). ATWCX return over 5 years is better than : 55.01 vs. RWICX (45.76).
ATWCXRWICXATWCX / RWICX
Total Expense Ratio1.741.06164%
Annual Report Gross Expense Ratio2.061.06194%
Fund Existence22 years23 years-
Gain YTD18.12017.615103%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets970M142B1%
Annual Yield % from dividends0.001.14-
Returns for 1 year15.508.89174%
Returns for 3 years68.6867.03102%
Returns for 5 years55.0145.76120%
Returns for 10 years73.5574.1399%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAMS37.064.06
+12.29%
NewAmsterdam Pharma Company NV
TRSG1.38N/A
N/A
Tungray Technologies
AIG81.30-1.87
-2.25%
American International Group
SCSC40.45-1.03
-2.48%
ScanSource
SGMO0.67-0.07
-9.12%
Sangamo Therapeutics